These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...br>
• new ARV drugs and regimens
• new recommendation on infant prophylaxis
• PrEP and PEP updates
• updates on co-infections and comorbidities management
It should be noted that these guidelines are meant for the operational level and are adapted and adopted in line with existing Myanmar context.
more
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
Regional action plan 2019-2023
(Published with Decision No. 3003/QðBYT dated 19/8/2009 of the Minister of Health)
Examining the infrastructure of the Russian and USA healthcare systems with respect to the management of HIV patients
Evaluation report
April 2013
Evaluation report
This report is part of the overall Ukrainian National AIDS programme evaluation conducted
in September 2012
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
July 2019
Policy brief
HIV Treatment
PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
HIV Treatment - Interim Guidance
Supplement to the 2016 consolidated Guidelines on the use of antiretroviral drugs for Treating and Preventing HIV infection
HIV Treatment